樂觀
$310.11
情境價格
$310.360
-2.638 (-0.85%)收盤時
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution.
Veeva Systems Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price is $310.36, with a forward P/E of 30.21, indicating reasonable valuation for growth. The gross margin stands at 75.00%, showcasing robust profitability. However, the RSI is at 75.29, suggesting it may be overbought in the short term, which is a risk to consider.
Wells Fargo
$330
2026-09-08
Wells Fargo
2026-09-08
目標價
$330
Citi
$273
2026-08-28
Citi
2026-08-28
目標價
$273
Truist
$305
2026-08-27
Truist
2026-08-27
目標價
$305
Stifel
$300
2026-08-27
Stifel
2026-08-27
目標價
$300
RBC Capital
$325
2026-08-27
RBC Capital
2026-08-27
目標價
$325
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Paul Sekhri Appointed Chair of iOnctura Board

Veeva Systems to Host 2026 Investor Day Virtually

IQVIA and Veeva Expand Partnership with New Standard Applications

Investment Opportunities in High-Growth Stocks Amid Rising Yields

Veeva Summit Accelerates Drug Development Innovations
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).
Veeva Systems Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price is $310.36, with a forward P/E of 30.21, indicating reasonable valuation for growth. The gross margin stands at 75.00%, showcasing robust profitability. However, the RSI is at 75.29, suggesting it may be overbought in the short term, which is a risk to consider.
14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。